These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 12442029)

  • 21. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa.
    Jeena PM; Pillay P; Pillay T; Coovadia HM
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):672-8. PubMed ID: 12150478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus and tuberculosis coinfection in children: challenges in diagnosis and treatment.
    Verhagen LM; Warris A; van Soolingen D; de Groot R; Hermans PW
    Pediatr Infect Dis J; 2010 Oct; 29(10):e63-70. PubMed ID: 20651637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis.
    Madhi SA; Gray GE; Huebner RE; Sherman G; McKinnon D; Pettifor JM
    Pediatr Infect Dis J; 1999 Sep; 18(9):800-5. PubMed ID: 10493341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study.
    Elenga N; Kouakoussui KA; Bonard D; Fassinou P; Anaky MF; Wemin ML; Dick-Amon-Tanoh F; Rouet F; Vincent V; Msellati P
    Pediatr Infect Dis J; 2005 Dec; 24(12):1077-82. PubMed ID: 16371869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of human immunodeficiency virus on response to treatment and recurrence rate in patients treated for tuberculosis: two-year follow-up of a cohort in Lusaka, Zambia.
    Elliott AM; Halwiindi B; Hayes RJ; Luo N; Mwinga AG; Tembo G; Machiels L; Steenbergen G; Pobee JO; Nunn PP
    J Trop Med Hyg; 1995 Feb; 98(1):9-21. PubMed ID: 7861484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.
    Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Outcomes of Childhood TB in Lagos, Nigeria.
    Adejumo OA; Daniel OJ; Adebayo BI; Adejumo EN; Jaiyesimi EO; Akang G; Awe A
    J Trop Pediatr; 2016 Apr; 62(2):131-8. PubMed ID: 26705331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and outcome in children admitted to a TB hospital in the Western Cape--the influence of HIV infection and drug resistance.
    Soeters M; de Vries AM; Kimpen JL; Donald PR; Schaaf HS
    S Afr Med J; 2005 Aug; 95(8):602-6. PubMed ID: 16201005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical correlates of tuberculosis co-infection in HIV-infected children hospitalized in Peru.
    Ramírez-Cardich ME; Kawai V; Oberhelman RA; Bautista CT; Castillo ME; Gilman RH
    Int J Infect Dis; 2006 Jul; 10(4):278-81. PubMed ID: 16540360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National scale-up of tuberculosis-human immunodeficiency virus collaborative activities in Myanmar from 2005 to 2016 and tuberculosis treatment outcomes for patients with human immunodeficiency virus-positive tuberculosis in the Mandalay Region in 2015.
    Theingi P; Harries AD; Wai KT; Shewade HD; Saw S; Win T; Thein S; Kyi MS; Nyunt Oo H; Aung ST
    Trans R Soc Trop Med Hyg; 2017 Sep; 111(9):402-409. PubMed ID: 29361150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome of Children With Presumptive Tuberculosis in Mbarara, Rural Uganda.
    Bonnet M; Nansumba M; Bastard M; Orikiriza P; Kyomugasho N; Nansera D; Boum Y; de Beaudrap P; Kiwanuka J; Kumbakumba E
    Pediatr Infect Dis J; 2018 Feb; 37(2):147-152. PubMed ID: 28787386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the human immunodeficiency virus on tuberculosis in children.
    Jeena PM; Mitha T; Bamber S; Wesley A; Coutsoudis A; Coovadia HM
    Tuber Lung Dis; 1996 Oct; 77(5):437-43. PubMed ID: 8959148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional status and its response to treatment of children, with and without HIV infection, hospitalized for the management of tuberculosis.
    Schaaf HS; Cilliers K; Willemse M; Labadarios D; Kidd M; Donald PR
    Paediatr Int Child Health; 2012 May; 32(2):74-81. PubMed ID: 22595213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected].
    Erokhin VV; Kornilova ZKh; Alekseeva LP
    Probl Tuberk Bolezn Legk; 2005; (10):20-8. PubMed ID: 16318255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis and human immunodeficiency virus co-infection in children: management challenges.
    Chintu C
    Paediatr Respir Rev; 2007 Jun; 8(2):142-7. PubMed ID: 17574158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.
    Ifebunandu NA; Ukwaja KN; Obi SN
    Trop Doct; 2012 Apr; 42(2):74-6. PubMed ID: 22431822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.
    Ballif M; Renner L; Claude Dusingize J; Leroy V; Ayaya S; Wools-Kaloustian K; Cortes CP; McGowan CC; Graber C; Mandalakas AM; Mofenson LM; Egger M; Kumara Wati KD; Nallusamy R; Reubenson G; Davies MA; Fenner L; ;
    J Pediatric Infect Dis Soc; 2015 Mar; 4(1):30-8. PubMed ID: 26407355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia.
    Getahun B; Ameni G; Biadgilign S; Medhin G
    BMC Infect Dis; 2011 May; 11():127. PubMed ID: 21575187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults.
    Wilson D; Nachega J; Morroni C; Chaisson R; Maartens G
    Int J Tuberc Lung Dis; 2006 Jan; 10(1):31-8. PubMed ID: 16466034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.